These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 6609193

  • 1. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
    Cheever MA, Greenberg PD, Irle C, Thompson JA, Urdal DL, Mochizuki DY, Henney CS, Gillis S.
    J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth.
    Cheever MA, Thompson JA, Kern DE, Greenberg PD.
    J Immunol; 1985 Jun; 134(6):3895-900. PubMed ID: 3872906
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antigen-specific cultured T cells can mediate tumor therapy and provide long-term immunologic memory in vivo.
    Cheever MA, Klarnet JP, Peace DJ, Greenberg PD.
    Prog Clin Biol Res; 1987 Jun; 244():49-58. PubMed ID: 3498958
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M, Kjaergaard J, Kuppen PJ, Nannmark U, Agger R, Hokland P, Basse P.
    In Vivo; 1999 Jun; 13(3):199-204. PubMed ID: 10459491
    [Abstract] [Full Text] [Related]

  • 11. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA, Schlom J, Abrams SI.
    Cell Immunol; 1999 May 25; 194(1):78-89. PubMed ID: 10357883
    [Abstract] [Full Text] [Related]

  • 12. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD, Malek TR, Shevach EM, Mond JJ.
    J Immunol; 1986 Oct 01; 137(7):2252-9. PubMed ID: 3093569
    [Abstract] [Full Text] [Related]

  • 13. Recombinant interleukin 2 stimulates in vivo proliferation of adoptively transferred lymphokine-activated killer (LAK) cells.
    Ettinghausen SE, Lipford EH, Mulé JJ, Rosenberg SA.
    J Immunol; 1985 Nov 01; 135(5):3623-35. PubMed ID: 3900213
    [Abstract] [Full Text] [Related]

  • 14. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
    Brake DA, Weidanz WP, Long CA.
    J Immunol; 1986 Jul 01; 137(1):347-52. PubMed ID: 2423609
    [Abstract] [Full Text] [Related]

  • 15. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro".
    Bandeira A, Larsson EL, Forni L, Pereira P, Coutinho A.
    Eur J Immunol; 1987 Jul 01; 17(7):901-8. PubMed ID: 3111860
    [Abstract] [Full Text] [Related]

  • 16. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD.
    Int Immunol; 2004 Sep 01; 16(9):1283-94. PubMed ID: 15262898
    [Abstract] [Full Text] [Related]

  • 17. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
    Chen W, Schweins E, Chen X, Finn OJ, Cheever MA.
    J Immunol; 1994 Oct 15; 153(8):3630-8. PubMed ID: 7930583
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the antigen-reactive T cell line mediating in vivo delayed type hypersensitivity established by antigen-induced interleukin 2.
    Kobayashi K, Cohen S, Yoshida T.
    J Exp Pathol; 1989 Oct 15; 4(3):163-79. PubMed ID: 2788724
    [Abstract] [Full Text] [Related]

  • 19. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA.
    Cancer Res; 2004 Nov 01; 64(21):8062-7. PubMed ID: 15520217
    [Abstract] [Full Text] [Related]

  • 20. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.